name: | Buprenorphine_1 |
ATC code: | N02AE01_1 | route: | intravenous |
n-compartments | 2 |
Buprenorphine is a semi-synthetic opioid used primarily for pain management and opioid dependence therapy. It acts as a partial agonist at mu-opioid receptors, providing analgesia and mitigating opioid withdrawal symptoms.
Pharmacokinetics after intravenous administration in healthy adults.
Hakomäki, H, et al., & Kokki, M (2021). Pharmacokinetics of buprenorphine in pregnant sheep after intravenous injection. Pharmacology research & perspectives 9(2) e00726–None. DOI:10.1002/prp2.726 PUBMED:https://pubmed.ncbi.nlm.nih.gov/33619904
Jensen, ML, et al., & Christrup, L (2007). Population pharmacokinetics of buprenorphine following a two-stage intravenous infusion in healthy volunteers. European journal of clinical pharmacology 63(12) 1153–1159. DOI:10.1007/s00228-007-0377-2 PUBMED:https://pubmed.ncbi.nlm.nih.gov/17874319
Pypendop, BH, et al., & Barter, LS (2023). Pharmacokinetics of buprenorphine and its metabolite norbuprenorphine in neutered male cats anesthetized with isoflurane. Veterinary anaesthesia and analgesia 50(4) 349–355. DOI:10.1016/j.vaa.2023.04.004 PUBMED:https://pubmed.ncbi.nlm.nih.gov/37270407